Novartis Slips Into Pfizer's Number One Pharma Slot Amid Leaderboard Shakeup
Executive Summary
Pfizer has dropped to number seven in our top pharma rankings after a long reign. AbbVie has risen to number three, growing through merger expansion.
You may also be interested in...
Pfizer Leads An Unusual Year For The Scrip 100
Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.
Roche Boosted By COVID-19 Antibody Revenues As Pandemic Recovery Progresses
Ronapreve and Actemra for COVID-19 indications padded the top-line. Roche raised its financial outlook for the year to mid-single digit growth.
Pfizer On Boosters, Kids And Prospects For A Long-Term COVID-19 Business
The company raised revenue guidance for its COVID-19 vaccine this year to a staggering $33bn from a prior estimate of $26bn.